Meox1 promotes hepatocellular carcinoma progression potentially via regulation of cell cycle and p21 expression

Read full text
Authors: Jie Ruan, Ying Xie, Chaoqun Zhang, Dianxing Sun
Cited by: 1
References: 37

Abstract

Meox1 is aberrantly expressed in several malignancies, but its role in hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate the effects of Meox1 on HCC cells and explore the underlying molecular mechanisms. Cell proliferation, colony formation, migration, invasion, and cell cycle distribution were assessed by CCK-8, clonogenic, Transwell, and flow cytometry assays, respectively. Protein expression was examined by Western blotting. Meox1 silencing significantly inhibited proliferation, clonogenic capacity, migration and invasion of HCC cells. Cell cycle analysis showed a reduction in G1-phase cells with a marked accumulation in the G2 phase following Meox1 knockdown. Western blot analysis revealed that suppression of Meox1 reduced p21CIP1/WAF1 expression. Meox1 contributest to HCC progression and may represent a potential therapeutic target.

Fields of Study & Subjects

Glutathione Transferases and Polymorphisms DNA Repair Mechanisms Redox biology and oxidative stress

Publication details

Journal / source
Cell Adhesion & Migration
Publisher
Informa UK Limited
Volume
20
Issue
1
Pages
2658289–2658289
Publication date
19 April 2026
Language
EN